- Home
- ACFN vs PSTV Comparison
ACFN vs PSTV Comparison
Compare ACFN & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACFN | PSTV |
|---|---|---|
| Founded | 1986 | 1996 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 46.4M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ACFN | PSTV |
|---|---|---|
| Price | $17.54 | $0.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 23.2K | ★ 3.1M |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,213,000.00 |
| Revenue This Year | N/A | $21.93 |
| Revenue Next Year | N/A | $279.39 |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.42 | $0.16 |
| 52 Week High | $33.00 | $1.22 |
Technical Indicators
Market Signals| Indicator | ACFN | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 32.14 |
| Support Level | $16.12 | $0.21 |
| Resistance Level | $17.20 | $0.32 |
| Average True Range (ATR) | 1.29 | 0.02 |
| MACD | -0.26 | -0.00 |
| Stochastic Oscillator | 5.38 | 1.77 |
Price Performance
Historical ComparisonAbout ACFN Acorn Energy Inc.
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).